CVS GroupCVSGF 90 ROC (Joel Greenblatt) % is 18.94% as of Dec. 2025, which is 33% below its 10-year median of 28.25. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $16.82 (Fairly Valued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, CVS Group ranks better than 62.33% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. CVS Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 18.94%.
The historical rank and industry rank for CVS Group's ROC (Joel Greenblatt) % or its related term are showing as below:
CVSGF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 17.4 Med: 28.25 Max: 44.33
Current: 19.97
During the past 13 years, CVS Group's highest ROC (Joel Greenblatt) % was 44.33%. The lowest was 17.40%. And the median was 28.25%.
CVSGF's ROC (Joel Greenblatt) % is ranked better than 62.33% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs CVSGF: 19.97
CVS Group's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.70% per year.
CVS Group (OTCPK:CVSGF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for CVS Group's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVSGF vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, CVS Group's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where CVS Group's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 18.94% mean?
CVS Group (CVSGF) has a ROC (Joel Greenblatt) % of 18.94% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on CVS Group and its competitors. This is 33% below median its historical median of 28.25. Over the past decade, CVS Group's ROC (Joel Greenblatt) % has ranged from 17.40 to 44.33. According to the industry distribution chart, CVS Group ranks #252 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 37.7%.
Is CVS Group's ROC (Joel Greenblatt) % too high?
CVS Group's current ROC (Joel Greenblatt) % of 18.94% is 33% below median its 10-year median of 28.25. Over the past 10 years, this metric has ranged from a low of 17.40 to a high of 44.33. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. CVS Group's value of 18.94% is 52% above this industry median. Based on the distribution chart, CVS Group ranks #252 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CVS Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #252 out of 669 companies for ROC (Joel Greenblatt) %. This puts CVS Group in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. CVS Group's value of 18.94% is 52% above this benchmark. Historically, CVS Group's own ROC (Joel Greenblatt) % has ranged from 17.40 to 44.33 over the past decade. While the company's 10-year median is 28.25 vs. the industry median of 12.46, CVS Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current ROC (Joel Greenblatt) % of 18.94% is 52% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current ROC (Joel Greenblatt) % is 18.94%, which is 33% below median its own 10-year median of 28.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Fairly Valued. The stock's GF Value™ is $16.82, compared to a current price of $15.65 — trading 7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 18.94%, which is 33% below median its 10-year median of 28.25 and 52% above the Healthcare Providers & Services industry median of 12.46. CVS Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For CVS Group (CVSGF), the current ROC (Joel Greenblatt) % is 18.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $15.65 is trading 7% below its estimated GF Value™ of $16.82.
GuruFocus considers CVS Group to be Fairly Valued.
Key valuation signals for CVSGF:
ROC (Joel Greenblatt) %: 18.94% (33% below median its 10-year median of 28.25)
GF Value™: $16.82 vs. price of $15.65 (7% below fair value)
Industry Position: 52% above the Healthcare Providers & Services median (#252 of 669)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score
Get the complete analysis for CVSGF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
